IDEAS home Printed from https://ideas.repec.org/a/tec/bioche/ojs13255.html

A proposal for improvement of the first-line treatment of advanced diabetic retinopathy

Author

Listed:
  • Meyer Elazar, Ph.D

    (214 Haalon St., Matta, Israel)

Abstract

Diabetic retinopathy (DR) can be resulted from high blood glucose levels that may damage the retinal pigment epithelium, located between the vascular choroids and the neurosensory retina, which functions as a barrier. The first-line treatment of DR comprises an anti-vascular endothelial growth factor (anti-VEGF) compound such as Avastin (bevacizumab), Lucentis (ranibizumab) and Eylea (aflibercept). Some patients suffering from static condition of advanced DR need a treatment that will lead to improvement of the DR condition, e.g., reduction of abnormal blood vessels on the optic disc and preventing further ischemic optic neuropathy. Thus, a combined simultaneous treatment of an anti-VEGF compound such as Avastin, or a biosimilar version, and oral administration of fucoxanthin that has a protective effect on the retina, optionally together with vitamin A, is proposed for treating advanced DR.

Suggested Citation

  • Meyer Elazar, Ph.D, 2025. "A proposal for improvement of the first-line treatment of advanced diabetic retinopathy," Technium BioChemMed: Journal of Multidisciplinary Research, Biology, Chemistry and Medicine ISSN 2734 - 7990, Technium Science, vol. 13, pages 189-195, October.
    • Handle: RePEc:tec:bioche:ojs:13255
    DOI: 10.47577/biochemmed.v13i.13255
    as

    Download full text from publisher

    File URL: https://techniumscience.com/index.php/biochemmed/article/view/13255
    Download Restriction: no
    File URL: https://libkey.io/10.47577/biochemmed.v13i.13255?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:tec:bioche:ojs:13255. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Anna Maria Golita (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.